Aurinia Pharmaceuticals, Inc. (AUPH)
15.22
-0.23
(-1.49%)
USD |
NASDAQ |
May 22, 16:00
15.22
0.00 (0.00%)
After-Hours: 20:00
Aurinia Pharmaceuticals Cash from Investing (Quarterly) : -18.08M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Xenon Pharmaceuticals, Inc. | -407.28M |
| Edesa Biotech, Inc. | 0.00 |
| ProMIS Neurosciences, Inc. | 0.00 |
| Medicus Pharma Ltd. | 0.00 |
| Kiniksa Pharmaceuticals International Plc | -31.92M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 32.56M |
| Cash from Financing (Quarterly) | -53.68M |
| Free Cash Flow | 166.93M |
| Free Cash Flow Per Share (Quarterly) | 0.2363 |
| Free Cash Flow to Equity (Quarterly) | 38.69M |
| Free Cash Flow to Firm (Quarterly) | 33.31M |
| Free Cash Flow Yield | 7.99% |